Home  >  TopNews
you can get e-magazine links on WhatsApp.Click here
Pioma_Lactic
Clinical Trials + Font Resize -

Eastern India braces for role in national and global multi-centric clinical trials

Nandita Vijay, Bengaluru
Friday, May 28, 2021, 08:00 Hrs  [IST]

Eastern India now braces up for a role in the national and global multi-centric clinical trials space. The region is keen to pitch and position itself has a key hub for human studies based on the disease manifestation and growing patient pool.

From access to patients, healthcare infrastructure along with a pool of qualified and trained clinicians, the states of the North East such as Bihar, Orissa and West Bengal are eager to be part of the human studies.

We have seen that these states are already engaged in a lot of studies and are keen to carry out more clinical trials in this part of the country, said Dr. Subhadeep Sinha, senior VP, clinical development and medical affairs, Hetero Drugs.

Academic and clinical research are disrupted because of the pandemic across government hospitals. Although no interventional studies are undertaken during this time, some observational studies especially on Covid positive cases are going on at the state and national level institutes, noted Prof Abhijit Hazra, Dean, IPGME&R, SSKM Hospital, Kolkata.

Among the key reasons which were impacting clinical trials in the eastern stated according to Dr Imliwati Longkumer, clinical trial manager, North East Cancer Hospital and Research Institute, Assam was the inclusion and exclusion criteria of study protocol which hindered subject enrolment.

At a recently concluded virtual round table organised by ISCR and Clini-Med Lifesciences on ‘Challenges and Opportunities of Clinical Research in Eastern India’ a panel of experts said even as there are considerable prospects, the pandemic has brought the human studies to a standstill.

Dr. Monjori Mitra, one of the investigators who participated in numerous clinical trials from East, said that while there was there is lot of potential in East, there was a need to hone the skills of the researchers to ensure a transparent working environment .

Dr Madhuchanda Kar, oncology investigator Peerless Hospital, Kolkata, emphasized that while patients never maintained their health records, the advent of hospital-based cancer registry made it easier to shortlist prospective trial subjects.

Stating that the North East states had tremendous potential for the indigenous drug development, Dr. Soumen Mukherjee, HOD, Allied Health Science & Department of Hospital Administration, ICFAI University, Tripura said that ISCR could collaborate with the clinical research to accelerate human studies.

Suneela Thatte, VP and head- R&D Solutions India, at IQVIA assured that they would try to help trial sites and investigators in capacity building of clinical research in the eastern India region.

Anirban Roy Chowdhury, VP, clinical research, Bharat Serums and Vaccines stated that though the The participation of Eastern states for clinical trials was far less compared to the rest of the country. There is a need for the entire ecosystem of clinical research to work together and here the Eastern stated needed to expedite the administrative processes.

Representing was the Dr. Malaya Singha, associate medical director, Parexel, Bhubaneswar said lot of job opportunities for clinical research aspirants in eastern India.

Snehendu Konar, and Clinical Trial Facilitator of Govt and Pvt Hospitals of West Bengal and Dr. Subhrojyoti Bhowmick, chairman, ISCR East Chapter moderated the event.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |